Partners

Sponsor GapSummit 2019

An unparalleled opportunity to showcase your organization to an international audience of biotech leaders and to connect with the next generation of leaders

GapSummit is made possible by the generous support of our sponsors. GapSummit 2019 offers sponsors a global platform to present their brand alongside the biggest change-makers in biotechnology, contribute to the conference program, as well as the opportunity to challenge and inspire 100 of the top Leaders of Tomorrow from around the world selected to attend.

For more information on sponsorship opportunities and to receive a sponsorship prospectus, contact GapSummit 2019 President, Mohamad Najia

Gold Sponsors

Biogen

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.

We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.


Bayer

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.


Bronze Sponsors

AstraZeneca/MedImmune

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines . MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal & Metabolic Diseases, and Infection and Vaccines.


Partners

The Broad Institute of MIT and Harvard

The Broad Institute of MIT and Harvard was launched in 2004 to improve human health by using genomics to advance our understanding of the biology and treatment of human disease, and to help lay the groundwork for a new generation of therapies.

The institute was founded to seize the opportunity that arose from the Human Genome Project — the international effort that successfully deciphered the entire human genetic code. Despite that accomplishment, scientists knew they still lacked a clear understanding of the genetic basis of disease, and how to translate that understanding into more effective prevention, diagnosis, and treatment.

The Broad Institute is an “experiment” in this new way of doing science. It spans some of Boston’s leading institutions (Harvard, MIT, and Harvard-affiliated hospitals) and scientific disciplines (biology, chemistry, medicine, computer science, and engineering). Today, the Broad community includes more than three thousand scientists, committed to advancing research in areas including infectious disease, cancer, psychiatric research, and cardiovascular disease.


Massachusetts Institute of Technology

MIT is driven by a shared purpose: to make a better world through education, research, and innovation. We are fun and quirky, elite but not elitist, inventive and artistic, obsessed with numbers, and welcoming to talented people regardless of where they come from.

Founded to accelerate the nation’s industrial revolution, MIT is profoundly American. With ingenuity and drive, our graduates have invented fundamental technologies, launched new industries, and created millions of American jobs. At the same time, and without the slightest sense of contradiction, MIT is profoundly global. Our community gains tremendous strength as a magnet for talent from around the world. Through teaching, research, and innovation, MIT’s exceptional community pursues its mission of service to the nation and the world.


Young European Biologists

Young European Biologists (YEB) is a non-profit student-run organisation for young scientists in the field of biology and biotechnology who are either studying or looking to study in Europe. Our aim is to improve the communication between universities from different countries and connect students to opportunities, by establishing our organization as the link between them. We strive to create a wide network promoting the exchange of ideas between young biologists across Europe and beyond.